Jiajin Yang - Concepedia

Author

Jiajin Yang

University of North Carolina at Chapel Hill ORCID

Also Known As

Bo Liu, Hewins, Peter, Jennette, J. Charles, Jia-Jin Yang, Jia-jin Yang, JiaJin Yang, Jiajin Yang, McInnis, Elizabeth A

Publications

891

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Central South University Xiangya Hospital Central South University Emory University Hospital Colorado Kidney Care

About

Jiajin Yang is an author at University of North Carolina at Chapel Hill specializing in medicine, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	288
2	Allergy	2	2	79
3	Cell Biology	2	2	69
4	Public Health	1	1	118
5	Epidemiology	1	1	118

Jiajin Yang

Publications

769

Citations

H-Index

Page 1

	Year	Citations
Anti–LAMP-2 Antibodies Are Not Prevalent in Patients With Antineutrophil Cytoplasmic Autoantibody Glomerulonephritis Aleeza J. Roth, Michael C. Brown, R. Neal Smith, Journal of the American Society of Nephrology	2011	121
DRB1*15 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans Yali Cao, John L. Schmitz, Jiajin Yang, Journal of the American Society of Nephrology GeneticsGenetic EpidemiologyImmunologyPathologyHuman Polymorphism	2011	118
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression Phyllis F. Cheung, Jiajin Yang, Rui Fang, Nature Communications	2022	88
HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p Yufan Zhou, Yun Huang, Kuan Hu, Cell Death and Disease	2020	78
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis Britta E. Jones, Jiajin Yang, Akhil Muthigi, Journal of the American Society of Nephrology	2016	57
ANCA patients have T cells responsive to complementary PR-3 antigen Jiajin Yang, David J. Bautz, Susan L. Hogan, Kidney International Autoimmune DiseaseT-regulatory CellImmunologyPathologyAntigen Processing	2008	52
Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy? Yun Huang, Zeyu Zhang, Yufan Zhou, OncoTargets and Therapy	2019	44
High Basal Activity of the PTPN22 Gain-of-Function Variant Blunts Leukocyte Responsiveness Negatively Affecting IL-10 Production in ANCA Vasculitis Yali Cao, Jiajin Yang, Kerry Colby, PLoS ONE ImmunologyImmune RegulationImmunologic MechanismP38 MapkInflammation	2012	42
The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay Jingjing Yang, Sa Mu, Meng Huang, Clinical Biochemistry Reference IntervalsAllergyElectrochemiluminescence ImmunoassayMedicineHealthy Female	2013	37
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study Jianbing Wu, An Li, Jiajin Yang, OncoTargets and Therapy	2017	35

Page 1